Revolution Medicines

ISIN US76155X1000

 | 

WKN A2PYWG

Market cap (in EUR)
28,459 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Show more Show less
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 28,459 m
EPS, EUR -6.10
P/B ratio 20.8
P/E ratio -
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR -
Net income, EUR -1,003 m
Profit margin -

What ETF is Revolution Medicines in?

There are 20 ETFs which contain Revolution Medicines. All of these ETFs are listed in the table below. The ETF with the largest weighting of Revolution Medicines is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI World UCITS ETF (Dist) 0.02%
Equity
World
7,907
UBS Core MSCI World UCITS ETF USD acc 0.02%
Equity
World
9,182
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) 0.05%
Equity
World
Health Care
Social/Environmental
507
iShares MSCI ACWI UCITS ETF USD (Acc) 0.02%
Equity
World
28,098
Amundi MSCI North America ESG Broad Transition UCITS ETF Dist 0.01%
Equity
North America
Social/Environmental
Climate Change
39
iShares MSCI USA Screened UCITS ETF USD (Dist) 0.03%
Equity
United States
Social/Environmental
1,383
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.02%
Equity
World
Social/Environmental
551
UBS Core MSCI World UCITS ETF hEUR acc 0.02%
Equity
World
816
UBS Core MSCI USA UCITS ETF EUR Hedged dis 0.03%
Equity
United States
194
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.27%
Equity
United States
Small Cap
213
iShares MSCI USA ESG Enhanced CTB UCITS ETF USD (Dist) 0.02%
Equity
United States
Social/Environmental
14,376
iShares MSCI World ESG Enhanced CTB UCITS ETF USD (Dist) 0.01%
Equity
World
Social/Environmental
765
iShares MSCI North America UCITS ETF 0.02%
Equity
North America
1,272
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.55%
Equity
United States
Health Care
Biotech
46
UBS Core MSCI World UCITS ETF USD dis 0.02%
Equity
World
1,863
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing 0.03%
Equity
North America
Social/Environmental
25
iShares MSCI World Screened UCITS ETF USD (Dist) 0.02%
Equity
World
Social/Environmental
1,115
iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist) 0.08%
Equity
United States
Momentum
13
UBS Core MSCI World UCITS ETF hGBP dis 0.02%
Equity
World
104
UBS Core MSCI USA UCITS ETF USD dis 0.03%
Equity
United States
1,270
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.